Jayesh Visaria, a veteran Pharma & Healthcare investment banker, and a director at Barclays India investment bank has put in his papers. Visaria, who’s head of healthcare & consumer at I Banking at Barclays, quit the global Bank after a stint of 8 years.

Along with an entrepreneur role, Visaria will work as an independent advisor to family offices and private equity funds, said sources.

A Barclays spokesperson declined to comment.

As a banker, Visaria has covered areas such as Pharma, hospitals, CROs, vaccines and diagnostics.

He was also involved in marquee deals such as Advent’s buyout in Suven LifeSciences, GIC’s investment in Asia Healthcare Holdings (AHH) – the TPG-backed healthcare platform, Care Hospitals’ sell-out process and Max Hospital sale to KKR-backed Radiant. Visaria was also involved with IPOs such as Dr Lal PathLabs, HealthCare Global Enterprises, and Aster DM Healthcare.

With 18 years of investment banking experience, Visaria started his career at JP Morgan.

Prior to Barclays, he was senior vice president at Kotak investment bank.In January, Mangesh Ghogre, the Executive Director and Head of Equity Capital Markets, Nomura India, had quit and moved to the US to pursue new opportunities.



Source link

Previous articleTAP Business Class: What to Know
Next articleInitial claims from Cyclone Gabrielle in New Zealand reach $890m

LEAVE A REPLY

Please enter your comment!
Please enter your name here